- Home
- PRTC vs CGC Comparison
PRTC vs CGC Comparison
Compare PRTC & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTC
- CGC
- Stock Information
- Founded
- PRTC 2015
- CGC 2009
- Country
- PRTC United States
- CGC Canada
- Employees
- PRTC N/A
- CGC N/A
- Industry
- PRTC Biotechnology: Pharmaceutical Preparations
- CGC Pharmaceuticals and Biotechnology
- Sector
- PRTC Health Care
- CGC Health Care
- Exchange
- PRTC Nasdaq
- CGC Nasdaq
- Market Cap
- PRTC 457.3M
- CGC 379.3M
- IPO Year
- PRTC N/A
- CGC N/A
- Fundamental
- Price
- PRTC $18.47
- CGC $1.63
- Analyst Decision
- PRTC Buy
- CGC Sell
- Analyst Count
- PRTC 1
- CGC 1
- Target Price
- PRTC $45.00
- CGC $2.00
- AVG Volume (30 Days)
- PRTC 2.0K
- CGC 10.3M
- Earning Date
- PRTC 08-28-2024
- CGC 02-07-2025
- Dividend Yield
- PRTC N/A
- CGC N/A
- EPS Growth
- PRTC N/A
- CGC N/A
- EPS
- PRTC N/A
- CGC N/A
- Revenue
- PRTC $468,000.00
- CGC $192,343,833.00
- Revenue This Year
- PRTC N/A
- CGC N/A
- Revenue Next Year
- PRTC $160.00
- CGC $2.26
- P/E Ratio
- PRTC N/A
- CGC N/A
- Revenue Growth
- PRTC N/A
- CGC N/A
- 52 Week Low
- PRTC $17.00
- CGC $1.58
- 52 Week High
- PRTC $34.00
- CGC $14.92
- Technical
- Relative Strength Index (RSI)
- PRTC 46.10
- CGC 34.35
- Support Level
- PRTC $18.35
- CGC $1.58
- Resistance Level
- PRTC $18.89
- CGC $1.97
- Average True Range (ATR)
- PRTC 0.43
- CGC 0.19
- MACD
- PRTC 0.00
- CGC -0.02
- Stochastic Oscillator
- PRTC 26.62
- CGC 3.79
About PRTC PureTech Health plc
PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.
About CGC Canopy Growth Corporation
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.